Gilead, working to improve cancer cell therapy, partners with California startup – BioPharma Dive

Posted: October 21, 2022 at 2:39 am

  1. Gilead, working to improve cancer cell therapy, partners with California startup  BioPharma Dive
  2. Kite and Refuge Biotechnologies Announce Exclusive License Agreement for Investigational Gene Expression Platform for Blood Cancers  Gilead Sciences
  3. Kite Pharma Licenses Refuge Biotechnologies Platform to Bolster CAR T-Cell Therapy Development  Precision Oncology News
  4. Gilead's Kite ties itself to Refuge's gene platform in blood cancer CAR-T deal  FierceBiotech
  5. View Full Coverage on Google News

See the original post here:
Gilead, working to improve cancer cell therapy, partners with California startup - BioPharma Dive

Related Posts